ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998